Anna M. Seekatz, Ph.D. - Publications

Affiliations: 
2013 Molecular Microbiology and Immunology University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Microbiology Biology

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Seekatz AM, Safdar N, Khanna S. The role of the gut microbiome in colonization resistance and recurrent infection. Therapeutic Advances in Gastroenterology. 15: 17562848221134396. PMID 36425405 DOI: 10.1177/17562848221134396  0.392
2020 Rao K, Seekatz A, Bassis C, Sun Y, Mantlo E, Bachman MA. Infection after Intestinal Dominance in Hospitalized Patients. Msphere. 5. PMID 32699120 DOI: 10.1128/mSphere.00450-20  0.318
2020 Nagao-Kitamoto H, Leslie JL, Kitamoto S, Jin C, Thomsson KA, Gillilland MG, Kuffa P, Goto Y, Jenq RR, Ishii C, Hirayama A, Seekatz AM, Martens EC, Eaton KA, Kao JY, et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nature Medicine. PMID 32066975 DOI: 10.1038/S41591-020-0764-0  0.414
2020 Collingwood A, Blostein F, Seekatz AM, Wobus CE, Woods RJ, Foxman B, Bachman MA. Epidemiological and Microbiome Associations Between and Vancomycin-Resistant Colonization in Intensive Care Unit Patients. Open Forum Infectious Diseases. 7: ofaa012. PMID 32010736 DOI: 10.1093/Ofid/Ofaa012  0.377
2019 Seekatz AM. Development of an alternative animal model to investigate host-microbe interactions. Ebiomedicine. PMID 31711971 DOI: 10.1016/J.Ebiom.2019.10.027  0.302
2019 Bassis C, Seekatz A, Dangana TE, Shimasaki T, Yelin RD, Schoeny M, Rhee Y, Ariston M, Lolans K, Cisneros EC, Aboushaala K, Thabit L, Murray J, Sheng J, Ollison S, et al. 2849. Gut Microbiota Differences at the Time of Medical Intensive Care Unit (MICU) Admission Are Associated with Acquisition of Multi-drug-Resistant Organisms (MDROs) Among Patients Not Already Colonized with an MDRO Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz359.154  0.331
2018 Shimasaki T, Seekatz A, Bassis C, Rhee Y, Yelin RD, Fogg L, Dangana T, Cisneros EC, Weinstein RA, Okamoto K, Lolans K, Schoeny M, Lin MY, Moore NM, Young VB, et al. Increased relative abundance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae within the gut microbiota is associated with risk of bloodstream infection in long-term acute care hospital patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30239622 DOI: 10.1093/Cid/Ciy796  0.425
2018 Seekatz AM, Bassis CM, Fogg L, Moore NM, Rhee Y, Lolans K, Weinstein RA, Lin MY, Young VB, Hayden MK. Gut Microbiota and Clinical Features Distinguish Colonization With Carbapenemase-Producing at the Time of Admission to a Long-term Acute Care Hospital. Open Forum Infectious Diseases. 5: ofy190. PMID 30151415 DOI: 10.1093/Ofid/Ofy190  0.44
2018 Seekatz AM, Wolfrum E, DeWald CM, Putler RKB, Vendrov KC, Rao K, Young VB. Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease. Anaerobe. PMID 29859301 DOI: 10.1016/J.Anaerobe.2018.05.017  0.373
2018 Seekatz AM, Theriot CM, Rao K, Chang YM, Freeman AE, Kao JY, Young VB. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Anaerobe. PMID 29654837 DOI: 10.1016/J.Anaerobe.2018.04.001  0.369
2018 Seekatz AM, Young VB. The Tangled Web of Interactions Between Host, Pathogen, and Microbiota in Clostridium difficile Infection. Gastroenterology. PMID 29601830 DOI: 10.1053/J.Gastro.2018.03.036  0.391
2017 Bassis CM, Moore NM, Lolans K, Seekatz AM, Weinstein RA, Young VB, Hayden MK. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. Bmc Microbiology. 17: 78. PMID 28359329 DOI: 10.1186/S12866-017-0983-9  0.312
2017 Seekatz A, Bassis CM, Lolans K, Yelin RD, Moore NM, Okamoto K, Rhee Y, Bell P, Dangana T, Sidimirova G, Weinstein RA, Fogg L, Lin MY, Young VB, Hayden MK. Longitudinal comparison of the microbiota during Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) acquisition in Long-Term Acute Care Hospital (LTACH) patients Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx162.115  0.355
2016 Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Núñez G, et al. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell. 167: 1339-1353.e21. PMID 27863247 DOI: 10.1016/J.Cell.2016.10.043  0.344
2016 Seekatz AM, Young VB. Infection: Modulation of Clostridium difficile infection by dietary zinc. Nature Reviews. Gastroenterology & Hepatology. PMID 27826138 DOI: 10.1038/Nrgastro.2016.177  0.406
2016 Nagao-Kitamoto H, Shreiner AB, Gillilland MG, Kitamoto S, Ishii C, Hirayama A, Kuffa P, El-Zaatari M, Grasberger H, Seekatz AM, Higgins PD, Young VB, Fukuda S, Kao JY, Kamada N. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Cellular and Molecular Gastroenterology and Hepatology. 2: 468-481. PMID 27795980 DOI: 10.1016/J.Jcmgh.2016.02.003  0.337
2016 Seekatz AM, Rao K, Santhosh K, Young VB. Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection. Genome Medicine. 8: 47. PMID 27121861 DOI: 10.1186/S13073-016-0298-8  0.403
2016 Seekatz A, Bassis CM, Lolans K, Okamoto K, Moore NM, Rhee Y, Bardowski L, Bell P, Salazar E, Dangana T, Sidimirova G, Weinstein RA, Fogg L, Lin MY, Young VB, et al. Fecal Microbiota Dynamics During Klebsiella pneumoniae carbapenemase (KPC) Acquisition in Long-Term Acute Care Hospital (LTACH) Patients Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1774  0.347
2016 Bassis CM, Seekatz A, Fogg L, Lolans K, Moore NM, Okamoto K, Rhee Y, Bardowski L, Bell P, Salazar E, Dangana T, Sidimirova G, Weinstein RA, Lin MY, Young VB, et al. Gut Microbiota and Clinical Predictors of Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage Among Patients at the Time of Admission to a Long-Term Acute Care Hospital (LTACH) Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1768  0.351
2016 Nagao-Kitamoto H, Shreiner A, Gillilland M, Kitamoto S, Kuffa P, Seekatz AM, Higgins P, Young V, Fukuda S, Kao JY, Kamada N. Su1898 Inflammatory Bowel Disease-Associated Gut Dysbiosis Impacts the Host Physiology and Colitis in Gnotobiotic Mice Gastroenterology. 150: S582-S583. DOI: 10.1016/S0016-5085(16)31997-7  0.367
2016 Nagao-Kitamoto H, Shreiner AB, Gillilland MG, Kitamoto S, Ishii C, Hirayama A, Kuffa P, El-Zaatari M, Grasberger H, Seekatz AM, Higgins PDR, Young VB, Fukuda S, Kao JY, Kamada N. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice Cmgh Cellular and Molecular Gastroenterology and Hepatology. 2: 468-481. DOI: 10.1016/j.jcmgh.2016.02.003  0.313
2015 Seekatz AM, Theriot CM, Molloy CT, Wozniak KL, Bergin IL, Young VB. Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease. Infection and Immunity. 83: 3838-46. PMID 26169276 DOI: 10.1128/Iai.00459-15  0.442
2015 Theriot CM, Schumacher CA, Bassis CM, Seekatz AM, Young VB. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection. Antimicrobial Agents and Chemotherapy. 59: 1596-604. PMID 25547352 DOI: 10.1128/Aac.04296-14  0.346
2015 Bassis CM, Seekatz A, Moore NM, Lolans K, Weinstein RA, Young VB, Hayden MK. Comparison of Stool versus Rectal Swab Samples from Long-Term Acute Care Hospital (LTACH) Patients for Microbiota Analysis Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.472  0.335
2014 Seekatz AM, Young VB. Clostridium difficile and the microbiota. The Journal of Clinical Investigation. 124: 4182-9. PMID 25036699 DOI: 10.1172/Jci72336  0.447
2014 Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, Young VB. Recovery of the gut microbiome following fecal microbiota transplantation. Mbio. 5: e00893-14. PMID 24939885 DOI: 10.1128/Mbio.00893-14  0.433
2013 Seekatz AM, Panda A, Rasko DA, Toapanta FR, Eloe-Fadrosh EA, Khan AQ, Liu Z, Shipley ST, Detolla LJ, Sztein MB, Fraser CM. Differential response of the cynomolgus macaque gut microbiota to Shigella infection. Plos One. 8: e64212. PMID 23755118 DOI: 10.1371/Journal.Pone.0064212  0.525
2013 Eloe-Fadrosh EA, McArthur MA, Seekatz AM, Drabek EF, Rasko DA, Sztein MB, Fraser CM. Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses. Plos One. 8: e62026. PMID 23637957 DOI: 10.1371/Journal.Pone.0062026  0.497
Show low-probability matches.